ABOS
NASDAQ · Biotechnology
Acumen Pharmaceuticals Inc
$2.40
+0.15 (+6.67%)
Open$2.30
Previous Close$2.25
Day High$2.47
Day Low$2.27
52W High$29.63
52W Low$11.07
Volume—
Avg Volume125.6K
Market Cap145.38M
P/E Ratio41.68
EPS$0.52
SectorBiotechnology
Analyst Ratings
Strong Buy
12 analysts
Price Target
+825.8% upside
Current
$2.40
$2.40
Target
$22.22
$22.22
$18.81
$22.22 avg
$35.10
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 32.13M | 32.40M | 26.28M |
| Net Income | 3.79M | 3.97M | 2.79M |
| Profit Margin | 11.8% | 12.2% | 10.6% |
| EBITDA | 5.50M | 6.39M | 4.32M |
| Free Cash Flow | 1.86M | 2.43M | 2.61M |
| Rev Growth | +20.9% | +8.5% | +2.1% |
| Debt/Equity | 0.36 | 0.35 | 0.35 |
Dividend
Dividend Yield1.38%
Annual Dividend$0.30
Payout Ratio57.6%
Frequencyquarterly
Ex-DividendMar 3, 2026
Pay DateMar 17, 2026
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |